Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SCHOOLBLAZER LIMITED Capital/Financing Update 2022

Sep 18, 2022

65751_rns_2022-09-18_9d5a6b51-8d08-4081-ad95-b07a22413432.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

==> picture [196 x 58] intentionally omitted <==

ASX ANNOUNCEMENT

DIVESTMENT COMPLETION

19[th] September 2022

Company Announcements Office Australian Securities Exchange Authorised by the Board for immediate release

PEGASUS DIVESTMENT

Further to the announcements of August 10, 2022 and September 15, 2022, Hancock and Gore (H&G) is pleased to advise that completion for the divestment of its 70% interest in Pegasus Healthcare Group (Pegasus) has now occurred.

For more information, please contact Executive Chair, Sandy Beard on 0412 308 263

ABOUT H&G

H&G is a diversified investment company with a focus on active management and driving shareholder returns through investing in a broad range of opportunities across private equity, ASX listed equities, funds management, real property, debt funding and other alternative investments. We seek to become a trusted partner of choice that aims to solve our partners’ problems, identifying and pursuing opportunities that benefit all parties.

HANCOCK AND GORE LIMITED ACN 009 657 961 I ASX:HNG Suite 803, 25 Bligh Street, Sydney NSW 2000 AUSTRALIA www.hancockandgore.com.au